Taken together, we propose that the peptide incorporation within the fiber protein represents a potentially powerful means for circumventing preexisting Ad5 immunity in clinical populations and could represent promising means for improving Ad5 efficacy clinically for local applications such as in ovarian cancer. The gene discussed is PSEN2; the disease is ovarian carcinoma.